Name of drug |
Type of cannabinoid |
Licensed indication |
---|---|---|
Nabilone (Cesamet ®) | Mixture of Δ9-THC, cannabinol, cannabidiol, and other cannabinoids | Treatment of chemotherapy-induced nausea and vomiting that has not responded to conventional antiemetics. Treatment of anorexia and weight loss in patients with AIDS |
Dronabinol | ||
(Marinol®) | Δ9-THC | Treatment of severe nausea and vomiting with chemotherapy that has not responded to conventional antiemetics and AIDS-related anorexia |
Sativex® | Buccal spray of cannabis sativa extract containing Δ9-THC (2.7 mg) and cannabidiol (2.5 mg) | Symptomatic relief of neuropathic pain and adjunctive analgesic treatment in advanced cancer for pain control despite opioid therapy |
Approved in Canada as adjunctive treatment for the symptomatic relief of neuropathic pain in multiple sclerosis | ||
Cannador® | Oral cannabis extract of cannabis sativa containing Δ9 THC (2.5 mg) and cannabidiol (1.25 mg) | |
Rimonabant | CB1 receptor antagonist | Treatment of obesity (licensed in European union) |
Clinically available cannabinoid drugs
Categories: